HUMALOG Mix25 100 units/ml Suspension for injection in vial / cartridge / KwikPen pre-filled pen Ref.[8012] Active ingredients: Insulin lispro

Source: European Medicines Agency (EU)  Revision Year: 2018  Publisher: Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ, Utrecht, The Netherlands

Product name and form

Humalog Mix25 100 units/ml, suspension for injection in vial.

Humalog Mix25 100 units/ml, suspension for injection in cartridge.

Humalog Mix25 100 units/ml KwikPen, suspension for injection in a pre-filled pen.

Pharmaceutical Form

Suspension for injection.

White suspension.

Qualitative and quantitative composition

Each ml contains 100 units insulin lispro* (equivalent to 3.5mg).

Humalog Mix25 consists of 25% insulin lispro solution and 75% insulin lispro protamine suspension.

Vial: Each vial contains 1000 units of insulin lispro in 10 ml suspension.

Cartridge: Each cartridge contains 300 units of insulin lispro in 3 ml suspension.

KwikPen: Each pre-filled pen contains 300 units of insulin lispro in 3 ml suspension. Each KwikPen delivers 1-60 units in steps of 1 unit.

* produced in E.coli by recombinant DNA technology.

For a full list of excipients, see section 6.1.

Active Ingredient Description
Insulin lispro

The primary activity of insulin lispro is the regulation of glucose metabolism.

List of Excipients

Protamine sulphate
m-Cresol
Phenol
Glycerol
Dibasic sodium phosphate 7H2O
Zinc oxide
Water for injections
Hydrochloric acid and sodium hydroxide may be used to adjust pH

Pack sizes and marketing

Vial

The suspension is contained in type I flint glass vials, sealed with butyl or halobutyl stoppers and secured with aluminium seals. Dimeticone or silicone emulsion may have been used to treat the vial stoppers.

10 ml Vial: Pack of 1. Not all packs may be marketed.

Cartridge

The suspension is contained in type I flint glass cartridges, sealed with butyl or halobutyl disc seals and plunger heads and secured with aluminium seals. Dimeticone or silicone emulsion may have been used to treat the cartridge plunger, and/or the glass cartridge.

3 ml Cartridge: Packs of 5 or 10. Not all packs may be marketed.

KwikPen

The suspension is contained in type I flint glass cartridges, sealed with halobutyl disc seals and plunger heads and secured with aluminium seals. Dimeticone or silicone emulsion may have been used to treat the cartridge plunger, and/or the glass cartridge. The 3 ml cartridges are sealed in a disposable pen injector, called the “KwikPen”. Needles are not included.

3 ml KwikPen: Packs of 5 or a multipack of 10 (2 packs of 5). Not all packs may be marketed.

Marketing authorization holder

Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ, Utrecht, The Netherlands

Marketing authorization dates and numbers

EU/1/96/007/005
EU/1/96/007/008
EU/1/96/007/024
EU/1/96/007/033
EU/1/96/007/034

Date of first authorisation: 30th April 1996
Date of last renewal: 30th April 2006

Drugs

Drug Countries
HUMALOG Austria, Australia, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, United States, South Africa

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.